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Abstract
Background Laparoscopic adrenalectomy has become the
gold-standard for the surgical treatment of most adrenal
lesions. This study evaluated the operative outcome of
laparoendoscopic single-site (LESS) retroperitoneoscopic
adrenalectomy (LESS-ARA) in comparison with the cur-
rent standard operation procedure.
Methods Between June and December 2009, 19 patients
underwent LESS-ARA, and their outcomes were compared
with a contemporary 1:2 matched-pair cohort of 38 patients
who underwent standard ARA by the same surgeon. In
LESS-ARA, a multichannel port was inserted through a
2.5- to 3.0-cm transverse skin incision below the tip of the
12th rib. The LESS-ARA procedure was performed using a
5-mm 308 laparoscopic camera and two standard laparo-
scopic instruments. The following parameters were com-
pared between the two groups: demographics, details of the
surgery, perioperative complications, postoperative visual
analog pain scale score, analgesic requirement, and short-
term measures of convalescence.
Results The ﬁnding showed that LESS-ARA and stan-
dard ARA were comparable in terms of the estimated blood
loss (30 vs 17.5 ml; p = 0.64), postoperative hospital stay
(6 vs 6 days; p = 0.67), and postoperative complications
(2 vs 3 patients; p = 1.00) for patients with similar base-
line demographics and median tumor size (2.1 vs 3.0;
p = 0.18) cm. The intraoperative hemodynamic values
were similar in the two groups. The LESS-ARA group had
a longer median operative time (55 vs 41.5 min; p =
0.0004), whereas the in-hospital use of analgesics was
signiﬁcantly less (5 vs 12 morphine equivalents; p = 0.03).
Conclusions The LESS retroperitoneoscopic adrenalec-
tomy approach is feasible and offers a superior cosmetic
outcome and better pain control, with perioperative out-
comes and short-term measures of convalescence similar to
those of the standard approach, albeit with a longer oper-
ative time.
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Minimal access surgery has inherent appeal for small
deeply seated target organs such as the adrenal glands. No
other tissue shows a greater distinction between the small
size of an organ and the size of the skin incision required
for open surgical exposure than that found in adrenal sur-
gery [1]. Laparoscopic adrenalectomy has therefore
become the gold standard for adrenal surgery [2]. The
anatomic localization of the adrenal glands within the
upper retroperitoneum has inspired surgeons to adopt the
retroperitoneal approach. Since February 2000, we have
been developing an anatomic retroperitoneoscopic adre-
nalectomy (ARA) technique [3, 4].
Although ARA has a lower morbidity than open surgery,
it still requires at least three incisions, each 0.5–2.5 cm in
length. Each of the incisions has the potential to increase
the risk of bleeding, pain, hernia, and internal organ
damage, compromising the cosmetic outcome [5].
A new alternative to the conventional laparoscopy is
laparoendoscopic single-site (LESS) surgery [6]. Early
clinical series have demonstrated the feasibility of LESS in
urologic procedures, including nephrectomy, pyeloplasty,
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DOI 10.1007/s00464-010-1506-zrenal cryotherapy, and varicocelectomy [7–9]. We describe
a series of patients undergoing LESS anatomic retroperi-
toneoscopic adrenalectomy (LESS-ARA) and compare the
outcomes with those of patients undergoing conventional
laparoscopy.
To our best knowledge, our efforts represent the ﬁrst
series of retroperitoneal laparoscopic adrenalectomy via a
single multilumen port and the ﬁrst series of LESS per-
formed in China. Our study also represents the ﬁrst com-
parison of the outcomes between LESS and the gold
standard laparoscopic adrenalectomy.
Materials and methods
Participants and study design
A retrospective serial case-control study design was used in
this study. Between June and December 2009, LESS-ARA
was performed for 19 patients with adrenal tumors after
informed consent was obtained. One experienced laparo-
scopic surgeon (X.Z.) performed all the procedures.
The LESS-ARA procedure was indicated only for uni-
lateral benign adrenal tumors. Patients with tumor diame-
ters greater than 4 cm were not included in the study
because the working space in those patients may represent
a challenge [10].
All the cases were evaluated by magnetic resonance
imaging preoperatively. The patient characteristics are
shown in Table 1. During the same period, 87 standard
ARA procedures were performed by the same surgeon.
From this cohort, we selected 38 patients to serve as the
control group in this study. The 38 patients were matched
in a 2:1 ratio to index LESS-ARA cases with respect to
patient age, body mass index (BMI), tumor size, laterality,
and surgical indication, respectively. No consideration or
analysis of surgical parameters and outcomes was made
until this control group had been selected based only on
preoperative variables. This study was approved by the
institutional review board of our hospital.
The data collected from both groups included demo-
graphics, details of the surgery, perioperative complica-
tions, and short-term measures of convalescence. The
operative time was calculated from the start of the skin
incision to skin closure. The visual analog pain scale
(VAPS) score was recorded from 24 h after operation to
discharge. The pain scale used ranged from 1 (minimal
pain) to 10 (worst). The analgesic use from the recovery
room to the moment of discharge was converted to mor-
phine equivalents.
Surgical procedures
The ARA technique is well established. The patient is
placed in the full ﬂank position (908). Pressure points are
fully padded. The table is ﬂexed, and the patient is secured
with adhesive tape.
For the patients receiving the LESS-ARA procedure, a
TriPort (Olympus, Advanced Surgical Concepts, Dublin,
Ireland) is used to provide multichannel access through a
single incision. A 5-mm 308 rigid laparoscope (Olympus
Medical, Tokyo, Japan) is used in all cases. Two conven-
tional laparoscopic (straight) instruments (e.g., forceps,
harmonic scalpel, and bipolar forceps) are used to perform
the procedures.
A 2.5- to 3-cm transverse skin incision is made along the
lower margin of the 12th rib in the midaxillary line
(Fig. 1). The underlying musculature is spared by blunt
splitting of the obliques and transversalis. The thoraco-
lumbar fascia is next exposed and penetrated for entrance
Table 1 Patient demographics
LESS-ARA Standard ARA p Value
No. of patients 19 38
Median age: years (Q1, Q3) 57.0 (54.0, 62.0) 57.0 (53.0, 62.0) 0.96
Male/female 8/11 21/17 0.35
Median BMI (Q1, Q3) 29.8 (26.9, 33.1) 29.0 (25.0, 33.4) 0.65
Median ASA score (Q1, Q3) 2 (2, 3) 2 (2, 3) 0.85
Laterality (right/left) 10/9 15/23 0.35
Median tumor size: cm (Q1, Q3) 2.1 (1.9, 2.6) 3.0 (2.0, 3.5) 0.18
No. with adrenal disease 0.86
Primary aldosteronism 7 15
Cushing’s syndrome 4 11
Nonfunctional tumor 5 7
Pheochromocytoma 3 5
LESS-ARA laparoendoscopic single-site retroperitoneoscopic adrenalectomy, BMI body mass index
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123to the retroperitoneum. The retroperitoneal space is ini-
tially developed using blunt ﬁnger dissection to push
the peritoneum forward. A balloon dilator (Chenhe Inc.,
Zhejiang Province, China) then is placed into the
retroperitoneal space and inﬂated with 800 ml of air. The
balloon is subsequently deﬂated, and the introducer of the
TriPort aids in the facile introduction of the internal ring
into the retroperitoneal space. The TriPort then is ﬁxed as
described previously [11]. Carbon dioxide is instilled
through the insufﬂation channel of the TriPort to a maxi-
mum pressure of 15 mmHg.
Internally, the LESS-ARA surgical technique duplicates
the standard ARA [3]. After the Gerota’s fascia is incised,
the ﬁrst dissection plane between the perirenal fat and the
anterior renal fascia located at the superomedial side of
the kidney is explored. The adrenal can be identiﬁed at the
initial stage of the operation.
Because all the adrenal tumors in this series were
smaller than 4 cm, the second dissection plane, between
the perirenal fat and the posterior renal fascia located on
the lateral side of the upper kidney pole, was omitted in
both groups. The dissections proceeded in the avascular
plane located on the parenchymal surface of the upper renal
pole. The adrenal vein was dealt with at the ﬁnal stage of
the surgery. A detailed photographic representation of the
LESS-ARA procedure is shown in Fig. 2.
The isolated adrenal tumor was directly retrieved
through the single-port site. Air pressure then was
decreased to between 5 and 6 mmHg to identify potential
bleeding sites, and complete hemostasis was conﬁrmed. A
rubber drainage catheter was left in situ through the inci-
sion when necessary. Fascia and skin were carefully
sutured to avoid the possible development of a hernia.
Fig. 1 Incision and port sites for the standard procedure and the
laparoendoscopic single-site (LESS) procedure. A Schematic repre-
sentation of port placement for LESS and standard retroperitoneo-
scopic adrenalectomies. Ports 1, 2, and 3 were used for standard
retroperitoneoscopic adrenalectomy. For the standard procedure, 1 is
a 5-mm port below the 12th rib in the posterior axillary line, 2 is a
12-mm port under the subcostal margin in the anterior axillary line,
and 3 is a 10-mm port above the iliac crest in the midaxillary line for
the laparoscope. The site indicated by 4 is a 2.5- to 3-cm transverse
skin incision made below the lower margin of the 12th rib in
the midaxillary line for the Triport used in the LESS procedure.
B Actual Triport placement for a right LESS retroperitoneoscopic
adrenalectomy
Fig. 2 Internal views of the
laparoendoscopic single-site
retroperitoneoscopic
adrenalectomy (LESS-ARA)
procedure. A Gerota’s fascia is
incised longitudinally along the
posterior peritoneal reﬂection
(white arrows). B The adrenal
tumor (AT) is identiﬁed in the
ﬁrst dissection plane between
the perirenal fat and the anterior
Gerota’s fascia (GF) located at
the superomedial side of the
upper kidney pole (UKP). C By
grasping the periadrenal fat
cephalad, the bottom of the
adrenal gland or tumor is
separated from the parenchymal
surface of the upper kidney
pole, after which the third
dissection plane is developed.
D The upper adrenal arteries
(UAA) are transected
Surg Endosc (2011) 25:2117–2124 2119
123Statistical analysis
Summary statistics are presented as the median and the
25th (Q1) and 75th (Q3) percentiles. Groups were com-
pared using chi-square (v
2) analysis, Fisher’s exact test,
and the Mann-Whitney U test, as appropriate. Statistical
signiﬁcance was set at a p value less than 0.05, and all
reported p values were two-sided. The data analysis was
accomplished with SPSS 13.0 (SPSS, Chicago, IL, USA).
Results
The baseline demographics were comparable between the
two groups in terms of patient age, gender, BMI, tumor
size, laterality, American Society of Anesthesiology (ASA)
class, and surgical indication. The median length of the
incision in the LESS-ARA group was 2.8 cm, and the
median total length of the three incisions in the standard
ARA group was 6.0 cm (p\0.0001). The LESS-ARA
patients had a longer median operative time (55 vs
41.5 min; p = 0.0004) but a signiﬁcantly lower in-hospital
analgesic requirement (5 vs 12 morphine equivalents;
p = 0.03) than their counterparts in the control group. Four
patients in the LESS-ARA group did not require any
postoperative analgesia, and only six patients needed pain
medication 24 h after the operation.
No intraoperative complications occurred in either
group. The median estimated blood loss (EBL) was 30 ml
for the LESS-ARA patients and 17.5 ml for the standard
ARA patients (p = 0.64). The pheochromocytomas in both
groups were excised successfully without any undesirable
hemodynamic oscillations. Neither rises in systolic blood
pressure to more than 150 mmHg nor decreases to less than
85 mmHg were observed in any of the patients. In addition,
neither tachycardic (110 bpm or more) nor bradycardic
(50 bpm or less) episodes were observed in either cohort.
Table 2 outlines the intraoperative results.
The two procedures were essentially similar in terms of
the time to oral intake resumption (p = 0.84), time to
ambulation (p = 0.14), postoperative hospital stay (p =
0.67), and convalescence (p = 0.29). Postoperative com-
plications occurred for two patients in the LESS-ARA
group, including one case each of angina and contralateral
atelectasis. In the standard ARA group, two cases of sub-
cutaneous emphysema and one case of radiating shoulder
pain occurred. All complications were minor and suc-
cessfully treated without any surgical intervention
(Table 3).
Discussion
Adrenal surgery represents one of the most successful
stories of laparoscopy, particularly in the realm of urology
[2]. Rigorous criteria must be fulﬁlled by any novel treat-
ment before it can become the gold standard. Compared
with the established treatment options, the novel alternative
must be superior (or at least equivalent) in terms of safety,
efﬁcacy, and treatment outcomes [12].
As clinical experience with LESS increases, several
crucial points remain, such as the overall intraoperative
safety and the postoperative convalescence, which could
potentially jeopardize the application of this technique. In
Table 2 Intraoperative results
LESS-ARA Standard ARA p Value
No. of patients 19 38
Median incision length: cm (Q1, Q3) 2.8 (2.5, 3.0) 6.0 (5.5, 6.5) \0.0001
Median operative time: min
a 55 (47, 63), 38–120 41.5 (33.75, 48.5), 25–110 0.0004
Median EBL: ml
a 30 (10, 100), 5–200 17.5 (10, 100), 5–150 0.64
Median intraoperative heart rate (bpm)
Maximum
a 93 (87, 98), 82–99 90.5 (84.75, 95), 80–100 0.27
Mininum
a 57 (52, 59), 50–60 56 (53, 58), 50–59 0.71
Intraoperative systolic pressure (mmHg)
Maximum
a 136 (127, 142), 121–145 131.5 (125.75, 136), 120–144 0.12
Minimum
a 101 (94, 104), 87–110 98 (91.25, 104), 86–110 0.45
Median dissection time (min)
First plane
a 35 (23, 40), 12–90 23 (15, 29), 10–90 0.013
Third plane
a 11 (10, 16), 4–29 10 (8, 12), 6–23 0.17
Peritoneum tear (%) 4 (21.1) 6 (15.8) 0.72
LESS-ARA laparoendoscopic single-site retroperitoneoscopic adrenalectomy, EBL estimated blood loss
a Reported as median (Q1, Q3), range
2120 Surg Endosc (2011) 25:2117–2124
123this report, we present a 1:2 paired comparison of LESS-
ARA and conventional ARA performed by a single sur-
geon. Rigorous case-by-case matching was performed to
ensure that the control subjects matched the cases as clo-
sely as possible with regard to numerous factors other than
outcome measures.
No previously published prospective studies have com-
pared LESS with standard laparoscopic surgery. Based on
retrospective matched-pair studies, consensus on the
advantages of LESS surgery has not been achieved. For
example, Raman et al. [13] and White et al. [14] found no
difference between nephrectomy and abdominal sacral
colpopexy in terms of perioperative outcomes or short-term
measures of convalescence. Tracy et al. [15] reported on a
cohort of patients undergoing LESS pyeloplasty with more
favorable surgical parameters in terms of median operative
times (207 vs 237.5 min; p = 0.001) and median EBL (30
vs 72.5 mL; p = 0.002).
Canes et al. [16] compared LESS and standard laparo-
scopic living donor nephrectomy. The mean warm ische-
mia time was longer in the LESS group (3 vs 6.1 min;
p\0.0001). However, allograft function was immediate
and comparable between the two groups at 1 and 3 months.
Measures of in-hospital morbidity were equivalent. The
LESS donor nephrectomy (LESS-DN) approach shortens
convalescence, as measured by days that oral pain medi-
cation is received after discharge, time off work, and time
to resolution of physical symptoms.
Similarly, in our study, in-hospital morphine equivalents
were superior in the LESS-ARA group. However, the two
groups had a comparable hospital stay (median, 6 vs
6 days), and we did not ﬁnd any signiﬁcant difference in
the short-term convalescence between the two groups.
Two major reasons for the prolonged hospital stay in
both groups might be the governmental health insurance
system in China (patients could stay in the hospital longer
than needed) and the preference of most patients for
staying in the hospital until their silk sutures are removed.
However, other postoperative data such as days to oral
intake, ambulation, and convalescence are comparable with
those of the previous retroperitoneoscopic adrenalectomy
study.
To our best knowledge, this study represents the ﬁrst
series of retroperitoneal adrenalectomies using a single
multilumen port. Already used in complex procedures, the
TriPort allowed us to perform the adrenalectomy through a
single small incision. Two case studies have been pub-
lished previously on the use of lateral transperitoneal LESS
for adrenalectomy, with operating times of 120 and
240 min, respectively [17, 18].
Hirano et al. [19] published the ﬁrst series of patients
who received single-port adrenalectomy in 2005. Through
a 4.5-cm incision, a 4-cm-diameter rectoscope tube was
used for direct visualization without insufﬂation. Although
this procedure was not truly laparoscopic, it provided a
platform for the evolution of single-port surgery. The
average operating time was 203 min. The mean EBL was
252 ml, and four patients received blood transfusions.
Walz and Alesina [20] reported ﬁve cases of posterior
retroperitoneal adrenalectomy using a two-port single-
incision technique by a surgeon handling the camera and
one instrument simultaneously. The procedure was tech-
nically challenging, and such a technique is unlikely to be
widely applicable given its difﬁculty.
Kageyama et al. [21] reported that a gasless and portless
endoscopic adrenalectomy could be accomplished via a
single minimal incision using a retroperitoneal approach.
The outcomes for all ﬁve single-incision laparoscopic
adrenalectomy procedures that have been published are
listed in Table 4 together with the results of the current
study for comparison.
Although umbilical LESS can be used for surgery and
leaves virtually no scars, a small LESS-ARA scar on the
back generally is acceptable to patients if it results in less
Table 3 Postoperative results
LESS-ARA Standard ARA p Value
No. of patients 19 38
Median morphine equivalent (mg)
a 5 (1,13), 0–18 12 (6,20), 1–25 0.03
Median VAPS score at 24 h (Q1, Q3) 5 (5, 6) 6 (5, 7) 0.48
Median VAPS score at discharge (Q1, Q3) 1 (1, 1) 1 (0, 2) 0.43
Median days to oral intake (Q1, Q3) 1 (1, 2) 1 (1, 2) 0.84
Median days to ambulation (Q1, Q3) 2 (2, 3) 2 (1, 2) 0.14
Median hospital stay: days (Q1, Q3) 6 (5, 8) 6 (5, 7.25) 0.67
No. of patients with complications (%) 2 (10.5) 3 (7.9) 1.00
Median convalescence days (Q1, Q3) 15 (12, 18) 14 (10, 16.25) 0.29
LESS-ARA laparoendoscopic single-site retroperitoneoscopic adrenalectomy, VAPS visual analog pain scale
a Reported as median (Q1, Q3), range
Surg Endosc (2011) 25:2117–2124 2121
123postoperative pain than a standard ARA. Given the ana-
tomic location of the adrenal gland, none of the published
transperitoneal LESS adrenalectomies were performed
through the umbilicus [17, 18].
Lengthening an incision has the potential to diminish the
cosmetic appeal of single-port surgery. Therefore, ablative
surgery of a small organ, such as an adrenalectomy, may be
the most appropriate for LESS. None of the LESS-ARA
cases needed extension of the incision for ultimate speci-
men extraction. However, our exclusion criteria limited
tumor size to 4 cm. A similar criterion and accurate
imaging will need to be adopted by other surgeons to
ensure that enlargement of the incision will not be neces-
sary for removal of the tumor.
Experience with retroperitoneal LESS for urologic dis-
eases is very limited [22, 23]. In urologic laparoscopy, the
retroperitoneal approach has some advantages including
more direct access to the retroperitoneal organs, less need
for visceral retraction, and elimination of the risk for
intraperitoneal contamination with tumor cells or infectious
organisms [24, 25]. Because the retroperitoneal space is
limited, articulable and curved instruments are not as
useful as in transperitoneal procedures. The current series
of LESS-ARA showed that conventional instrumentation
is efﬁcient in minimizing the impact of the reduced
triangulation, fog evacuation, and clashing of instruments.
However, our extensive experience with standard ARA
also is considered to be paramount for the success we had
with the LESS-ARA technique.
Overall, our study conﬁrms that the retroperitoneal
approach is technically efﬁcient for LESS surgery because
it takes advantage of the naturally existing anatomic planes
of retroperitoneal organs. Developing an optimal process of
dissection and identifying the adrenal gland without
destruction of the surrounding anatomical structures were
our ﬁrst impetus to develop ARA [3]. Although the median
operative time was signiﬁcantly longer in the LESS group
(by approximately 13.5 min), intraoperative issues, such as
the adequacy of exposure of the dissection planes around
the adrenal gland and manipulation of the adrenal central
vein, could be achieved akin to those in the standard ARA
approach.
The majority of the extra time required for the surgery
comprised dissection of the ﬁrst plane because of the long
distance from the skin incision to this area and the extre-
mely small working space in this phase of the procedure.
However, we believe that morbidly obese patients also
could beneﬁt from such retroperitoneoscopic access [26,
27]. Although most of the patients in our LESS series were
slender, the maximal BMI was 36.5 kg/m
2, and nine
Table 4 Comparison with previously published experiences with single-minimal-incision adrenalectomy
Kageyama et al.
[21]
Hirano et al. [19] Castellucci et al.
[17]
Cindolo et al. [18] Walz and Alesina [20] Current study
No. of
patients
30 54 1 1 5 19
Tumor
size: cm
(range)
2.7 (0.5–6.5) 2.6 (0.5–4.5) 4.5 4.0 2.9 (1.0–4.0) 2.4 (1.6–4.0)
BMI 24.1(17.3–28.8) 24.5 ± 3.6 – 29.7 – 29.6
(22.8–36.5)
Approach Lateral
retroperitoneal
Lateral
retroperitoneal
Lateral
transperitoneal
Lateral
transperitoneal
Posterior retroperitoneal Lateral
retroperitoneal
Length of
incision:
cm
(range)
5.6 (3–9) 4.5 2.0 3.0 1.5 2.7 (2.5–3.0)
Operation
time:
min
(range)
147 (83–240) 203 (92–320) 120 240 54 (35–70) 61.6 (38–120)
EBL: ml
(range)
139 (5–470) 252 (10–1700) 125 20 \20 53.2 (5–200)
Comments Gasless,
portless
endoscopic
Gasless, via a 4-cm-
diameter and 13.7-
cm-length
rectoscope
Three 5-mm ports
inserted through
a single incision
First case of an
adrenalectomy with
a single multilumen
port
Two-port single-incision,
with one surgeon handling
the camera and one
instrument
Data are given as the means and range
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123patients had a BMI greater than 30 kg/m
2. Obesity did not
cause any difﬁculties during port set or dissection in any of
these patients.
Nevertheless, a prospective, randomized, controlled trial
would be the optimal design for comparing the different
surgical approaches. In the absence of such a trial, com-
parative studies can provide important insights. This study
constitutes the ﬁrst analysis comparing LESS with the gold
standard adrenalectomy. Although almost all comparative
analyses have been performed without excluding the
learning curve effect, our study demonstrates the compa-
rable safety and efﬁcacy of LESS-ARA when the proce-
dures are performed by an experienced surgeon.
The LESS retroperitoneoscopic adrenalectomy is feasi-
ble, offering perioperative outcomes and short-term mea-
sures of convalescence comparable with those of the
standard approach, albeit with a longer operative time.
Further large-scale prospective studies of LESS are needed
to demonstrate its safety, determine selection criteria, and
deﬁne its beneﬁts over conventional laparoscopic surgery.
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